At the end of the latest market close, Cogent Biosciences Inc. (COGT) was valued at $11.25. In that particular session, Stock kicked-off at the price of $11.23 while reaching the peak value of $11.44 and lowest value recorded on the day was $10.73. The stock current value is $10.87.Recently in News on November 14, 2022, Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results. Phase 3 PEAK trial initiated comparing bezuclastinib + sunitinib vs. sunitinib alone in second line gastrointestinal stromal tumor (GIST) patients; initial safety and pharmacokinetic data from lead-in phase to be presented at CTOS 2022. You can read further details here
Cogent Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $18.07 on 09/06/22, with the lowest value was $3.79 for the same time period, recorded on 05/13/22.
Cogent Biosciences Inc. (COGT) full year performance was 22.41%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cogent Biosciences Inc. shares are logging -39.85% during the 52-week period from high price, and 186.81% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.79 and $18.07.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 872667 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Cogent Biosciences Inc. (COGT) recorded performance in the market was 26.69%, having the revenues showcasing -33.31% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 729.59M, as it employees total of 77 workers.
The Analysts eye on Cogent Biosciences Inc. (COGT)
During the last month, 0 analysts gave the Cogent Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 13.48, with a change in the price was noted +0.58. In a similar fashion, Cogent Biosciences Inc. posted a movement of +5.64% for the period of last 100 days, recording 909,212 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for COGT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Cogent Biosciences Inc. (COGT)
Raw Stochastic average of Cogent Biosciences Inc. in the period of last 50 days is set at 4.52%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.38%. In the last 20 days, the company’s Stochastic %K was 13.23% and its Stochastic %D was recorded 15.04%.
Considering, the past performance of Cogent Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 26.69%. Additionally, trading for the stock in the period of the last six months notably improved by 128.84%, alongside a boost of 22.41% for the period of the last 12 months. The shares increased approximately by -2.25% in the 7-day charts and went up by -19.30% in the period of the last 30 days. Common stock shares were lifted by -33.31% during last recorded quarter.